Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

TBX4-PRECIS TBX4 enhancer based precision gene targeting for lung health

Coordinator
Justus-Liebig-Universitaet Giessen, Germany
Runs
1 August 2026 to 31 January 2028
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101334858

What the project is doing

In the project's own words, from its summary on CORDIS.

Chronic respiratory diseases (CRDs) represent a major global health burden, with limited therapeutic options available. Gene therapy offers significant potential; however, current approaches often lack organ specificity, resulting in off-target effects. TBX4-PRECIS is a novel lung-specific gene delivery platform based on a uniquely engineered genetic sequence that enables precise targeting of therapeutic genes to the lung.

Unlike conventional promoter-based systems, TBX4-PRECIS provides highly specific, carrier-agnostic expression of transgenes or antisense molecules in lung tissue, thereby improving targeting precision and minimizing off-target activity.

Topics

Who is involved

OrganisationCityCountryRole
Justus-Liebig-Universitaet GiessenGiessenGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI